Investment
Features
FeesSafety
Academy
More
Pluang+

Worthington Steel Q1 earnings and revenue miss estimates amid steel sector challenges

Company Fundamentals
06 Oct 2026
Gordon Thompson
View Source
Bearish
Worthington Steel Q1 earnings and revenue miss estimates amid steel sector challenges

Worthington Steel reported fiscal Q1 2027 earnings per share of $0.57 and revenue of $2.73 billion, both below analyst expectations of $0.92 per share and $3.14 billion revenue. The company's high price-to-earnings ratio of 109.11 suggests a premium valuation despite the earnings miss. Financially, Worthington Steel maintains a moderate debt-to-equity ratio of 0.33 and a strong current ratio of 1.46, indicating solid liquidity. These results reflect ongoing challenges in the steel industry, and investors will watch how the company adapts in coming quarters.

Worthington Steel's Q1 FY2027 earnings missed estimates with EPS of $0.57 versus $0.92 expected. For readers following basic materials, here is Pluang's market snapshot as of Oct 07, 2026 19:12 WIB: Of 38 priced US basic materials stocks, 7 rose and 28 fell. Notable movers include TECK at USD 66.00 with a -1.64% change and a typical hold time of 12 days, SCCO at USD 201.00 down 1.60% with 69% sell order activity, and B at USD 40.11 down 1.50% with 68% buy order activity.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
59 minutes ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
1 hour ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App